Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Neurocrine Biosciences (NBIX) Shares Outstanding (Diluted Average) (2016 - 2025)

Historic Shares Outstanding (Diluted Average) for Neurocrine Biosciences (NBIX) over the last 15 years, with Q4 2025 value amounting to $102.5 million.

  • Neurocrine Biosciences' Shares Outstanding (Diluted Average) fell 115.72% to $102.5 million in Q4 2025 from the same period last year, while for Dec 2025 it was $102.5 million, marking a year-over-year decrease of 115.72%. This contributed to the annual value of $102.5 million for FY2025, which is 115.72% down from last year.
  • As of Q4 2025, Neurocrine Biosciences' Shares Outstanding (Diluted Average) stood at $102.5 million, which was down 115.72% from $102.5 million recorded in Q3 2025.
  • Neurocrine Biosciences' 5-year Shares Outstanding (Diluted Average) high stood at $104.3 million for Q3 2024, and its period low was $97.1 million during Q1 2023.
  • Over the past 4 years, Neurocrine Biosciences' median Shares Outstanding (Diluted Average) value was $101.8 million (recorded in 2025), while the average stood at $101.2 million.
  • In the last 5 years, Neurocrine Biosciences' Shares Outstanding (Diluted Average) surged by 669.41% in 2024 and then crashed by 202.12% in 2025.
  • Neurocrine Biosciences' Shares Outstanding (Diluted Average) (Quarter) stood at $97.9 million in 2021, then grew by 3.17% to $101.0 million in 2023, then increased by 2.67% to $103.7 million in 2024, then decreased by 1.16% to $102.5 million in 2025.
  • Its Shares Outstanding (Diluted Average) was $102.5 million in Q4 2025, compared to $102.5 million in Q3 2025 and $101.8 million in Q2 2025.